Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re NAV and Interim Dividend

3 Aug 2021 11:31

RNS Number : 4204H
Maven Income and Growth VCT 3 PLC
03 August 2021
 

Maven Income and Growth VCT 3 PLC

 

Unaudited Net Asset Value (NAV) and Interim Dividend

 

The Directors of Maven Income and Growth VCT 3 PLC (the Company) confirm that the unaudited NAV of the Company as at 31 May 2021 was 60.76p per Ordinary Share. This is an increase of 2.51p since the previously announced NAV of 58.25p as at 28 February 2021, and represents an uplift of 4.31%. The NAV increase is largely attributable to several profitable realisations, all of which completed at valuations ahead of carrying value, alongside uplifts to the valuations of companies that are delivering growth in recurring revenues. In addition, on 22 July 2021, GEN InCode was successfully floated on AIM, raising £17 million and achieving a market capitalisation at listing of £42 million.

 

The Board is pleased to declare that an interim dividend of 1.25p per Ordinary Share, in respect of the year ending 30 November 2021, will be paid on 10 September 2021 to Shareholders on the register at close of business on 13 August 2021. Since the Company's launch, and after receipt of this latest dividend, 90.42p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying a dividend is to reduce the NAV of the Company by the total cost of the distribution.

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted. Terms & conditions of the scheme, together with a mandate form, are available from the Company's website at: www.mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 10 September 2021, should ensure that a mandate form, or CREST instruction if appropriate, is submitted prior to the dividend election date of 27 August 2021.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its interim results for the six months ended 31 May 2021 has been or will be notified to a regulatory information service.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

3 August 2021

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBGGDIRDGDGBX
Date   Source Headline
4th May 20102:43 pmRNSIssue of Equity
30th Apr 201011:09 amRNSAnnual Information Update
6th Apr 201011:19 amRNSIssue of Equity
1st Apr 20105:24 pmRNSIssue of Equity
8th Mar 20105:53 pmRNSAnnual Financial Report
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:14 amRNSTotal Voting Rights
14th Dec 20099:59 amRNSChange of Name
7th Dec 200911:03 amRNSTransaction in Own Shares
26th Nov 200912:18 pmRNSResult of EGM
2nd Nov 20094:34 pmRNSChange of Adviser
30th Oct 20093:47 pmRNSNotice of EGM
16th Oct 200912:09 pmRNSInterim Management Statement
1st Sep 20099:39 amRNSTotal Voting Rights
3rd Aug 20093:53 pmRNSTransaction in Own Shares
27th Jul 20093:31 pmRNSCorrection to record date
24th Jul 20094:48 pmRNSHalf Yearly Report
10th Jun 200911:48 amRNSChange of Adviser
9th Apr 20093:55 pmRNSAGM Statement
9th Apr 20091:06 pmRNSInterim Management Statement
6th Apr 20092:57 pmRNSChange of Adviser
30th Mar 200911:05 amRNSAnnual Information Update
30th Mar 200910:15 amRNSAnnual Report and Accounts
10th Mar 200911:20 amRNSAnnual Report and Accounts
6th Mar 200910:26 amRNSC Ordinary shares (on conversion to Ordinary)
2nd Mar 200912:50 pmRNSConversion of Securities
17th Oct 20082:14 pmRNSInterim Management Statement
16th Oct 20082:54 pmRNSResult of EGM
29th Aug 200811:17 amRNSCirc re GM, and issue of inte
16th Jul 20084:34 pmRNSDirectorate Change
15th Jul 20084:17 pmRNSInterim Results
25th Apr 20083:24 pmRNSResult of AGM
17th Apr 200810:23 amRNSInterim Management Statement
7th Mar 20084:01 pmRNSAnnual Information Update
29th Feb 20084:23 pmRNSAnnual Report and Accounts
6th Feb 200811:51 amRNSFinal Results
20th Jul 20075:05 pmRNSInterim Results
12th Jun 20073:14 pmRNSAnnual Information Update
7th Jun 200712:47 pmRNSResult of AGM
7th Feb 20075:13 pmRNSFinal Results
20th Dec 20064:52 pmRNSTotal Voting Rights
8th Nov 20063:08 pmRNSNet Asset Value(s)
14th Jul 20065:11 pmRNSInterim Results
29th Jun 200610:51 amRNSDirector/PDMR Shareholding
29th Jun 200610:50 amRNSDirector/PDMR Shareholding
29th Jun 200610:40 amRNSDirector/PDMR Shareholding
24th May 20069:31 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.